| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |